Company Filing History:
Years Active: 2018-2020
Title: The Innovative Contributions of Bradley Earl Reaman
Introduction
Bradley Earl Reaman is a notable inventor based in Indianapolis, IN, who has made significant contributions to the field of pharmaceuticals. He holds two patents that focus on novel compounds for treating various types of cancer. His work is particularly relevant in the ongoing fight against this devastating disease.
Latest Patents
Reaman's latest patents include the development of 1-tetrahydropyranylcarbonyl-2,3-dihydro-1H-indole compounds for treating cancer. This invention relates to certain novel 2,3-dihydro-1H-indole compounds, pharmaceutical compositions comprising these compounds, and methods of using them to treat cancer. The cancers targeted by these compounds include melanoma, acute myeloid leukemia, chronic lymphocytic leukemia, colorectal cancer, breast cancer, lung cancer, ovarian cancer, and several others. His second patent also focuses on 2,3-dihydro-1H-indole compounds with similar applications in cancer treatment.
Career Highlights
Reaman is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to contribute to innovative research and development in the pharmaceutical industry. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.
Collaborations
Some of Reaman's coworkers include Jolie Anne Bastian and Jiehao Chen, who collaborate with him on various projects related to cancer treatment and pharmaceutical innovations.
Conclusion
Bradley Earl Reaman's contributions to cancer research through his patented inventions highlight the importance of innovation in the pharmaceutical industry. His work continues to pave the way for new treatments that could significantly impact patient outcomes.